Fullerton Fund Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-78,060
| Closed | -$8.32M | – | 165 |
|
|
2024
Q1 | $8.32M | Sell |
78,060
-21,990
| -22% | -$2.34M | 0.39% | 41 |
|
|
2023
Q4 | $9.95M | Buy |
100,050
+5,781
| +6% | +$575K | 0.58% | 38 |
|
|
2023
Q3 | $9.74M | Buy |
+94,269
| New | +$9.74M | 0.68% | 29 |
|
|
2023
Q1 | – | Sell |
-4,174
| Closed | -$750K | – | 86 |
|
|
2022
Q4 | $750K | Sell |
4,174
-46,451
| -92% | -$8.34M | 0.06% | 60 |
|
|
2022
Q3 | $5.99M | Buy |
+50,625
| New | +$5.99M | 0.45% | 44 |
|
|
2021
Q4 | – | Sell |
-63,384
| Closed | -$24.4M | – | 66 |
|
|
2021
Q3 | $24.4M | Buy |
+63,384
| New | +$24.4M | 1.48% | 21 |
|